Welcome back,

Access study resources, meeting materials, working group updates, and collaborative tools to support leukemia research and care across Canada.

Featured News

CLSG Events

Latest Past Events

EHA 2026 Update

We invite you to join us to discuss selected acute leukemia abstracts from EHA 2026

Management of FLT3-Mutated AML: What’s New in 2026?

We invite you to join a discussion about the management of FLT3-mutated AML and what’s new in 2026. The discussion will cover the impact of newly available Quizartinib on Canadian practice, and recent advances in FLT3-ITD MRD testing.